AUPH FY 2025 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$283M+20.4% YoY

Gross Profit

$250M88.5% margin

Operating Income

$105M37.1% margin

Net Income

$287M101.5% margin

EPS (Diluted)

$2.07

Cash Flow

Operating Cash Flow

$136M

Free Cash Flow

$135M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$752M

Total Liabilities

$170M

Stockholders' Equity

$581M

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$283M	$235M	+20.4%
Gross Profit	$250M	$207M	+21.0%
Operating Income	$105M	-$5M	+2338.4%
Net Income	$287M	$6M	+4893.1%